FHTX vs SNPS · rev $22.6M vs P/E 63, rev $7.05B
Foghorn Therapeutics Inc (FHTX) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
FHTX currently screens at market cap $237.8M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the FHTX and SNPS stock pages for the full models.
Not investment advice.